structure glp 1 PDB-101: Molecule of the Month: GLP-1 Receptor Agonists GLP-1R agonist 13 | GLP-1

Researchers found that newer medications appear to keep patients on therapy longer, while side effects remain a major reason for discontinuation

In phase 2 diabetes research, retatrutide improved glycaemic control and reduced body weight, and Lillys phase 3 topline results reported HbA1C reductions of around 1.7% to 2.0% at 40 weeks

An orotate phophoribosyltransferase enzyme was isolated from Rhodotorula mucilaginosa and its patulin degrading activity was evaluated in apple juice (Tang et al., 2019)

L-Carnitine and acylcarnitines: Mitochondrial biomarkers for precision medicine

Expression of fluorescently tagged membrane proteins in S